SCHEMBL14215518

SCHEMBL14215518

CCCN(CC(=O)OC)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 6/20 0.55
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BCHE P06276 2/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ACKR3 P25106 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3364898 0.90 NPC1 (0.52) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL7611509 0.89 NPC1 (0.50) KDM4EALDH1A1MAPTTDP1PTPN1
SCHEMBL8575850 0.88 ACHE (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2
Bromide SCHEMBL20547060 0.87 NPC1 (0.49) KDM4EALDH1A1MAPTTDP1PTPN1
SCHEMBL4847536 0.86 RORC (0.50) RORCALDH1A1BCHETSHRHSD17B10
SCHEMBL12198408 0.85 NPC1 (0.47) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL28479321 0.85 HDAC3 (0.51) HDAC3HDAC1HDAC2HDAC8KDM4E
SCHEMBL5520572 0.84 HCRTR2 (0.46) RORCHDAC3HDAC4HDAC1HDAC7
SCHEMBL5541857 0.83 RORC (0.56) RORCHDAC3HDAC4HDAC1HDAC7
SCHEMBL28562689 0.83 POLB (0.46) RORCHDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative SHIONOGI & CO. LTD. (JP) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103139-A1 3-Carbamoyl-2-Pyridone Derivative CNR1, CNR2, HRH4 RORC 603/4885HDAC3 544/4885HDAC4 2011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.